SCHEMBL6407532

SCHEMBL6407532

CC(CO)N(C)S(=O)(=O)c1ccc(C2=CC=CCC2=S)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HTR7 P34969 1/20 0.32
AGER Q15109 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
MMP1 P03956 1/20 0.31
MMP9 P14780 1/20 0.31
MMP13 P45452 1/20 0.31
ADAM17 P78536 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769197 1.00 ADAMTS4 (0.36) ADAMTS4ADAMTS5PSEN1PSEN2APH1B
SCHEMBL6324718 0.88 ADAMTS4 (0.34) ADAMTS4ADAMTS5ALDH1A1HPGDHTR7
SCHEMBL6324360 0.78 SIGMAR1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6322302 0.77 TDO2 (0.43) ADAMTS4ALDH1A1MMP1MMP9MMP13
SCHEMBL6326033 0.77 MMP2 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6323684 0.74 ADAMTS4 (0.62) ADAMTS4ADAMTS5MMP1MMP9MMP13
SCHEMBL6323686 0.74 ADAMTS4 (0.62) ADAMTS4ADAMTS5MMP1MMP9MMP13
SCHEMBL6321475 0.72 ESR1 (0.49) ADAMTS4PSEN1PSEN2APH1BNCSTN
SCHEMBL6321479 0.72 ESR1 (0.49) ADAMTS4PSEN1PSEN2APH1BNCSTN
SCHEMBL6325881 0.70 PSEN1 (0.52) ADAMTS4PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014840-A1 Thiol sulfonamide metalloprotease inhibitors PHARMACIA CORPORATION 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014840-A1 Thiol sulfonamide metalloprotease inhibitors MMP12, MMP13, MMP3 ADAMTS4 33/4885ADAMTS5 23/4885PSEN1 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.